Gainers
- Orphazyme ORPH shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 102.2 million shares, making up 1405.39% of its average full-day volume over the last 100 days. The company's market cap stands at $276.8 million.
- Bellerophon Therapeutics BLPH stock rose 19.11% to $4.86. As of 12:30 EST, Bellerophon Therapeutics's stock is trading at a volume of 4.5 million, which is 7285.22% of its average full-day volume over the last 100 days. The company's market cap stands at $46.2 million.
- Genprex GNPX stock increased by 15.07% to $3.8. As of 12:30 EST, Genprex's stock is trading at a volume of 1.0 million, which is 149.8% of its average full-day volume over the last 100 days. The company's market cap stands at $179.8 million.
- HUTCHMED (China) HCM stock rose 13.59% to $29.41. As of 12:30 EST, this security is trading at a volume of 558.4K shares, making up 229.31% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 billion.
- Adamis Pharmaceuticals ADMP stock increased by 10.19% to $1.14. The current volume of 5.1 million shares is 63.35% of Adamis Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $168.9 million.
- Sundial Growers SNDL shares moved upwards by 10.09% to $0.98. Trading volume for this security as of 12:30 EST is 156.6 million, which is 71.26% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.8 billion.
Losers
- Gemini Therapeutics GMTX stock decreased by 28.77% to $6.96 during Wednesday's regular session. Gemini Therapeutics's stock is trading at a volume of 3.7 million shares as of 12:30 EST. This is 1552.2% of its average full-day volume over the last 100 days.
- Second Sight Medical EYES shares declined by 19.93% to $5.08. The current volume of 7.5 million shares is 119.68% of Second Sight Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $141.9 million.
- Millendo Therapeutics MLND stock declined by 16.67% to $1.15. As of 12:30 EST, Millendo Therapeutics's stock is trading at a volume of 4.6 million, which is 222.04% of its average full-day volume over the last 100 days. The company's market cap stands at $21.8 million.
- Idera Pharmaceuticals IDRA stock declined by 16.59% to $1.32. Trading volume for this security as of 12:30 EST is 17.4 million, which is 521.33% of its average full-day volume over the last 100 days. The company's market cap stands at $65.9 million.
- BioXcel Therapeutics BTAI shares decreased by 13.71% to $31.8. BioXcel Therapeutics's stock is trading at a volume of 1.5 million shares as of 12:30 EST. This is 433.06% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $783.2 million.
- Keros Therapeutics KROS shares fell 11.99% to $46.28. Trading volume for Keros Therapeutics's stock is 491.4K as of 12:30 EST. This is 364.69% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in